| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/23/2003 | EP1303274A1 Method of promoting smoking cessation |
| 04/23/2003 | EP1303272A2 Benzothiazole derivatives |
| 04/23/2003 | EP1254131A4 Extraction of flavonoids |
| 04/23/2003 | EP1250055A4 Immune modulation with death receptor-induced apoptosis |
| 04/23/2003 | EP1222183B1 Benzopyran derivatives |
| 04/23/2003 | EP1220863B1 Purine derivatives |
| 04/23/2003 | EP1218378B1 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 04/23/2003 | EP1154794B1 Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group |
| 04/23/2003 | EP1146862B1 Pharmaceutical compositions |
| 04/23/2003 | EP1140925B1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines |
| 04/23/2003 | EP1117681B1 Rho-cocotoxin peptides having selective alpha-1 adrenoceptor activity |
| 04/23/2003 | EP1045830B1 Alpha-aminoamide derivatives useful as analgesic agents |
| 04/23/2003 | EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 04/23/2003 | EP1009397B1 Use of n,n-bis (phenylcarbamoylmethyl) dimethylammonium chloride and derivatives in the treatment of chronic pain |
| 04/23/2003 | EP0910379B1 Plaster for the transdermal application of pergolide |
| 04/23/2003 | CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels |
| 04/23/2003 | CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413206A Non peptide tachykinin receptor antagonists |
| 04/23/2003 | CN1413197A 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 04/23/2003 | CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof |
| 04/23/2003 | CN1413192A Substituted indole mannich bases |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413181A Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 04/23/2003 | CN1413116A Pharmaceutical composition for preventing and treating erectile impotence using purified sumsoo extract |
| 04/23/2003 | CN1413111A Use of dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants |
| 04/23/2003 | CN1413110A Pharmaceutical composition |
| 04/23/2003 | CN1413107A Use of hypoglycemic agent for treating impaired clucose metabolism |
| 04/23/2003 | CN1413105A Novel method of treatment |
| 04/23/2003 | CN1413100A Local prevention or amelioration of pain from surgically closed wounds |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1411863A Clematis liquor |
| 04/23/2003 | CN1411862A Compound Huonaoshu medicine for curing encephalopathy and its preparation method |
| 04/23/2003 | CN1411849A Preparation for relieving alcoholism |
| 04/23/2003 | CN1411848A Chinese medicine liquor for clearing and activating channels and collaterals |
| 04/23/2003 | CN1411811A 血液循环改善剂 Blood circulation improving agent |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/23/2003 | CN1106390C Tachykinin receptor antagonist substituted methyl keto-morpholine crystal form |
| 04/23/2003 | CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions |
| 04/23/2003 | CN1106379C 2-propyl valeramide and 2-propyl valeramide derivative and medical use as anticonvulsants |
| 04/23/2003 | CN1106196C Application of Odenping medicine for treating migraine pain |
| 04/23/2003 | CN1106195C Use of thazolinedione derivatives and related antihyperglycemic agents in treatment of disease states at risk for progressing to non-insulin-dependent diabetes mellitus |
| 04/23/2003 | CN1106194C 组合物 The composition |
| 04/23/2003 | CN1106191C Methyl-naphthyl-oxythiophene-propyl amine enteric pellets |
| 04/23/2003 | CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives |
| 04/22/2003 | US6552223 N-hydroxacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | US6552192 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 04/22/2003 | US6552189 Anhydrous mirtazapine crystals and process for preparing the same |
| 04/22/2003 | US6552168 Inhibition of apoptosis via attenuation of caspase activity should therefore be useful in the treatment of human diseases where inappropriate apoptosis is prominent or contributes to disease pathogenesis |
| 04/22/2003 | US6552088 Biphenyl derivatives |
| 04/22/2003 | US6552086 For therapy of psychiatric and neurological disorders |
| 04/22/2003 | US6552077 Kidney disorders |
| 04/22/2003 | US6552076 Anticarcinogenic agents; controlling apoptosis |
| 04/22/2003 | US6552075 Therapeutic compounds and methods of use |
| 04/22/2003 | US6552071 Methods for treating cell death diseases and inflammation |
| 04/22/2003 | US6552062 For therapy of central nervous system disorders; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea, and obesity |
| 04/22/2003 | US6552057 Serotonin 5-HT3 receptor partial activator |
| 04/22/2003 | US6552049 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans |
| 04/22/2003 | US6552046 Cisapride |
| 04/22/2003 | US6552044 Indane or dihydroindole derivatives |
| 04/22/2003 | US6552043 Benzimidazolinyl piperidines as CGRP ligands |
| 04/22/2003 | US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 04/22/2003 | US6552036 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives |
| 04/22/2003 | US6552031 Synergistic analgesic combination of oxycodone and rofecoxib |
| 04/22/2003 | US6552019 Inhibitors of p38 |
| 04/22/2003 | US6552017 Substituted heterocycle fused gamma-carbolines |
| 04/22/2003 | US6552015 Azabicycloalkane derivatives and therapeutic uses thereof |
| 04/22/2003 | US6552012 Heteroaryl diazabicycloalkanes, their preparation and use |
| 04/22/2003 | US6552003 Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF |
| 04/22/2003 | US6552000 Anticonvulsant derivatives useful in treating autism |
| 04/22/2003 | US6551792 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy |
| 04/22/2003 | US6551626 Composition containing pyrrolizidine-alkaloid-free petasites |
| 04/22/2003 | US6551618 Compositions and methods for delivery of agents for neuronal regeneration and survival |
| 04/22/2003 | US6551612 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 04/22/2003 | CA2292673C Pharmaceutical compositions containing eletriptan hemisulphate |
| 04/22/2003 | CA2287054C 1,3,8-triazaspiro¬4,5|decanone compounds as orl1-receptor agonists |
| 04/22/2003 | CA2281580C Quinoxalinediones |
| 04/22/2003 | CA2264960C External formulation containing loxoprofen |
| 04/22/2003 | CA2117471C Benzisoxazole derivatives and pharmaceutical compositions containing them |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031971A1 Reagent for detecting risk factor for alzheimer's disease, detection kit therefor and method of detecting risk factor for alzheimer's disease using the same |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031614A1 Low molecular weight gtpase rhot |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031584A2 Axon repair |
| 04/17/2003 | WO2003031568A2 Intracellular signaling molecules |
| 04/17/2003 | WO2003031468A1 Therapeutic and diagnostic molecules that are capable of interacting with socs proteins |
| 04/17/2003 | WO2003031462A2 Nogo receptor-mediated blockade of axonal growth |
| 04/17/2003 | WO2003031459A2 Modulation of the expression of genes dependent on stat-1 |
| 04/17/2003 | WO2003031445A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031439A1 Antidepressant chroman and chromene derivatives of 3-(1,2,3,6-tetrahydro-4-pyridinyl)-1h-indole |
| 04/17/2003 | WO2003031438A1 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
| 04/17/2003 | WO2003031436A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | WO2003031435A1 Pyrazole derivatives as glycine transporter inhibitors |